Enzyme replacement for acute pancreatitis recovery
Part of Digestive system clinical trials.
This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You had an episode of acute pancreatitis in the last 12 months and are now stable.
- You have symptoms of poor digestion (like stomach pain, bloating, or diarrhea) after the pancreatitis.
- You have not taken pancreatic enzyme supplements for at least 1 week before the study starts.
- If you have had necrotizing pancreatitis, you must have completed all treatment for it.
- Your weight is between 88 and 264 pounds.
- If you can become pregnant, you must use birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new blood test to measure how well your pancreas works. It may help people with chronic pancreatitis understand their condition and quality of life.
This trial tests a new medicine (ANG003) for people with cystic fibrosis who have severe pancreatic problems. It looks at how safe and effective the medicine is, and whether it helps with digestion.
This trial tests whether pancreatic enzyme replacement therapy (PERT) helps patients with severe acute pancreatitis who have significant pancreatic damage and weight loss. The treatment may improve digestion and help regain weight.
This trial tests if a pancreatic enzyme replacement therapy (PERT) helps weight loss caused by tumors in the head of the pancreas. It may improve nutrition for people with advanced pancreatic cancer.
This trial tests whether enzymes from microbes work as well as enzymes from pigs to help people with chronic pancreatitis digest food better. It aims to find a treatment that reduces symptoms like pain and poor digestion.
This study tests a new pancreatic enzyme medicine (called NHS7108) for people with exocrine pancreatic insufficiency (EPI). EPI means your pancreas doesn't make enough enzymes to break down food properly. The study aims to see if this new medicine is safe and works well to help your body absorb nutrients.
Hear when a new Exocrine Pancreatic Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.